Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications - Archive ouverte HAL Access content directly
Journal Articles Cancers Year : 2021

Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications

(1, 2) , (1, 2) , (1, 2) , (1, 2, 3)
1
2
3

Abstract

A high expression of the phosphoprotein osteopontin (OPN) has been associated with cancer progression in several tumor types, including breast cancer, hepatocarcinoma, ovarian cancer, and colorectal cancer (CRC). Interestingly, OPN is overexpressed in CRC and is associated with a poor prognosis linked to invasion and metastasis. Here, we review the regulation and functions of OPN with an emphasis on CRC. We examine how epigenetic and genetic regulators interact with the key signaling pathways involved in this disease. Then, we describe the role of OPN in cancer progression, including proliferation, survival, migration, invasion, and angiogenesis. Furthermore, we outline the interest of using OPN as a clinical biomarker, and discuss if and how osteopontin can be implemented as a routine assay in clinical laboratories for monitoring CRC patients. Finally, we discuss the use of OPN an attractive, but challenging, therapeutic target.
Fichier principal
Vignette du fichier
cancers-13-03793.pdf (1.37 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

inserm-03447091 , version 1 (24-11-2021)

Identifiers

Cite

Katyana Amilca-Seba, Michèle Sabbah, Annette Larsen, Jérôme Denis. Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications. Cancers, 2021, 13 (15), pp.3793. ⟨10.3390/cancers13153793⟩. ⟨inserm-03447091⟩
33 View
36 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More